Magyar Dermatológiai Társulat IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Helyszín: Mátraháza, Residence Ózon**** Conference & Wellness Hotel A rendezvény Web oldala: http://www.impulse.org.hu/venue-and-accommodation.html The subject of the 2013 IMPULSE symposium will be
"Molecular mechanisms and therapeutic targets in inflammation".
The meeting will bring together basic scientists, clinicians and representatives of the pharmaceutical industry to discuss the understanding and therapy of inflammatory diseases.
IMPULSE 2013 will focus on the following topics:
B cells as therapeutic targets
Therapeutic targeting of T cells
Ion channels and inflammation
Therapeutic targets in inflammation
Microvesicles & Inflammation/Disease
Development and application of therapeutic antibodies in inflammatory diseases
Participants with academic, clinical and industrial relations are kindly invited to create this melting pot: IMPULSE
Magyar Immunológiai Társaság IMPULSE Szimpózium (Mátraháza, 2013.08.31-09.03.)
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Tudományos információ: Anna ERDEI, Gabriella SÁRMAY, Imre KACSKOVICS, János MATKÓ, Attila MÓCSAI, György PANYI, József PRECHL Címe: www.impulse.org.hu E-mail: impulse@impulse.org.hu Munkahely neve: Arts and Graphs (Conference Secreteriat) E-mail: impulse@impulse.org.hu Helyszín: Mátraháza, A rendezvény Web oldala: http://www.impulse.org.hu IMPULSE: IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013, an EFIS-EJI Symposium
Deadline for submission of abstracts: July 1, 2013
Early registration: June 15, 2013
Further information is available on the website.
EFIS bursaries (covering registration fee and full accomodation) for talented scientist under 35 are still available. Applicants have to send their abstract and CV to matko@elte.hu and cc to anna.erdei@freemail.hu
Make sure to submit your abstract in time and don't forget to apply for an EFIS bursary if you are under 35!
SCIENTIFIC PROGRAM
Molecular mechanisms and therapeutic targets in inflammation
MAJOR TOPICS:
-B cells
-T cells
-Ion channels and inflammation
-Therapeutic targets in inflammation
-Microvesicles & Inflammation or Disease
-Development and application of therapeutic antibodies in inflammatory diseases Kapcsolódó dokumentumok (2)
Magyar Szülészeti-Nőgyógyászati Ultrahang Társaság 28th World Congress on Ultrasound in Obstetrics and Gynecology (20-24 October 2018, Singapore)
Rendezvény kezdete: 2018.10.20.Rendezvény vége: 2018.10.24. Helyszín: Singapore, A rendezvény Web oldala: https://www.isuog.org/events/world-congress.html ISUOG's World Congress is the main annual scientific meeting for clinicians who use or research ultrasound in obstetrics and gynecology.
As one of the most culturally rich and dynamically progressive cities of the world, Singapore is a perfect destination for our internationally renowned forum of education, clinical updates and networking for ultrasound professionals. By attending ISUOG 2018 you’ll hear from a fusion of world-renowned speakers presenting on the most up-to-date research, benefit from our partnerships with other societies, including the Australasian Society for Ultrasound in Medicine (ASUM), and experience a leading event in ultrasound.
Important deadlines
20 August Early bird registration deadline
20 October Pre-Congress courses and Basic Training
21 October Congress opens
More details on the website: https://www.isuog.org/events/world-congress.html >>
Magyar Dermatológiai Társulat ESMO 2018 Annual Congress
Rendezvény kezdete: 2018.10.19.Rendezvény vége: 2018.10.23. Helyszín: Németország, 81823 München, Messegelände, Messe Munich A rendezvény Web oldala: http://www.esmo.org/Conferences/ESMO-2018-Congress It is with much pleasure and anticipation that we announce the ESMO 2018 Congress will take place 19-23 October 2018, in Munich, Germany. ESMO invites all oncology stakeholders: researchers, clinicians, industry partners, patient advocates and members of the press to mark your calendars for the annual ESMO Congress in 2018.
ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.
We invite you to save the date.
Josep Tabernero, ES, ESMO President 2018-2019
Solange Peters, CH, ESMO 2018 Scientific Chair
Andrés Cervantes, ES, ESMO 2018 Educational Chair